ICU MEDICAL INC (ICUI) Stock Fundamental Analysis

NASDAQ:ICUI • US44930G1076

142.02 USD
-5.71 (-3.87%)
At close: Feb 12, 2026
142.02 USD
0 (0%)
After Hours: 2/12/2026, 8:00:02 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

4

ICUI gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 186 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and the financial health of ICUI get a neutral evaluation. Nothing too spectacular is happening here. ICUI has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

  • In the past year ICUI was profitable.
  • In the past year ICUI had a positive cash flow from operations.
  • In multiple years ICUI reported negative net income over the last 5 years.
  • Of the past 5 years ICUI 4 years had a positive operating cash flow.
ICUI Yearly Net Income VS EBIT VS OCF VS FCFICUI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

1.2 Ratios

  • With a decent Return On Assets value of -0.18%, ICUI is doing good in the industry, outperforming 73.12% of the companies in the same industry.
  • The Return On Equity of ICUI (-0.35%) is better than 73.66% of its industry peers.
  • ICUI's Return On Invested Capital of 2.86% is fine compared to the rest of the industry. ICUI outperforms 70.43% of its industry peers.
  • Measured over the past 3 years, the Average Return On Invested Capital for ICUI is significantly below the industry average of 8.83%.
  • The last Return On Invested Capital (2.86%) for ICUI is above the 3 year average (1.36%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -0.18%
ROE -0.35%
ROIC 2.86%
ROA(3y)-1.71%
ROA(5y)1.06%
ROE(3y)-3.65%
ROE(5y)0.24%
ROIC(3y)1.36%
ROIC(5y)3.41%
ICUI Yearly ROA, ROE, ROICICUI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10

1.3 Margins

  • With a decent Operating Margin value of 5.63%, ICUI is doing good in the industry, outperforming 70.43% of the companies in the same industry.
  • In the last couple of years the Operating Margin of ICUI has declined.
  • ICUI's Gross Margin of 36.47% is on the low side compared to the rest of the industry. ICUI is outperformed by 71.51% of its industry peers.
  • In the last couple of years the Gross Margin of ICUI has remained more or less at the same level.
Industry RankSector Rank
OM 5.63%
PM (TTM) N/A
GM 36.47%
OM growth 3Y-26.21%
OM growth 5Y-22.36%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.48%
GM growth 5Y-1.46%
ICUI Yearly Profit, Operating, Gross MarginsICUI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40 50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ICUI is destroying value.
  • ICUI has more shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, ICUI has more shares outstanding
  • The debt/assets ratio for ICUI is higher compared to a year ago.
ICUI Yearly Shares OutstandingICUI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
ICUI Yearly Total Debt VS Total AssetsICUI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

  • An Altman-Z score of 2.23 indicates that ICUI is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 2.23, ICUI is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
  • The Debt to FCF ratio of ICUI is 21.21, which is on the high side as it means it would take ICUI, 21.21 years of fcf income to pay off all of its debts.
  • The Debt to FCF ratio of ICUI (21.21) is better than 69.35% of its industry peers.
  • ICUI has a Debt/Equity ratio of 0.62. This is a neutral value indicating ICUI is somewhat dependend on debt financing.
  • With a Debt to Equity ratio value of 0.62, ICUI is not doing good in the industry: 62.90% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.62
Debt/FCF 21.21
Altman-Z 2.23
ROIC/WACC0.3
WACC9.69%
ICUI Yearly LT Debt VS Equity VS FCFICUI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B

2.3 Liquidity

  • ICUI has a Current Ratio of 2.45. This indicates that ICUI is financially healthy and has no problem in meeting its short term obligations.
  • ICUI's Current ratio of 2.45 is in line compared to the rest of the industry. ICUI outperforms 50.54% of its industry peers.
  • ICUI has a Quick Ratio of 1.19. This is a normal value and indicates that ICUI is financially healthy and should not expect problems in meeting its short term obligations.
  • ICUI has a Quick ratio of 1.19. This is in the lower half of the industry: ICUI underperforms 67.20% of its industry peers.
Industry RankSector Rank
Current Ratio 2.45
Quick Ratio 1.19
ICUI Yearly Current Assets VS Current LiabilitesICUI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 40.14% over the past year.
  • ICUI shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -5.28% yearly.
  • The Revenue has decreased by -0.84% in the past year.
  • The Revenue has been growing by 13.47% on average over the past years. This is quite good.
EPS 1Y (TTM)40.14%
EPS 3Y-5.58%
EPS 5Y-5.28%
EPS Q2Q%27.67%
Revenue 1Y (TTM)-0.84%
Revenue growth 3Y21.86%
Revenue growth 5Y13.47%
Sales Q2Q%-9.48%

3.2 Future

  • ICUI is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 14.56% yearly.
  • The Revenue is expected to grow by 2.95% on average over the next years.
EPS Next Y23.37%
EPS Next 2Y14.84%
EPS Next 3Y14.98%
EPS Next 5Y14.56%
Revenue Next Year-4.9%
Revenue Next 2Y-3.64%
Revenue Next 3Y-1.17%
Revenue Next 5Y2.95%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
ICUI Yearly Revenue VS EstimatesICUI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 500M 1B 1.5B 2B 2.5B
ICUI Yearly EPS VS EstimatesICUI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2 4 6 8 10

More info and screens

Find the best growth stocksShow best growing peers

6

4. Valuation

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 17.84, ICUI is valued on the expensive side.
  • Based on the Price/Earnings ratio, ICUI is valued cheaper than 83.87% of the companies in the same industry.
  • ICUI's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.67.
  • A Price/Forward Earnings ratio of 17.31 indicates a rather expensive valuation of ICUI.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of ICUI indicates a rather cheap valuation: ICUI is cheaper than 84.41% of the companies listed in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 27.69, ICUI is valued a bit cheaper.
Industry RankSector Rank
PE 17.84
Fwd PE 17.31
ICUI Price Earnings VS Forward Price EarningsICUI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • 84.41% of the companies in the same industry are more expensive than ICUI, based on the Enterprise Value to EBITDA ratio.
  • Based on the Price/Free Cash Flow ratio, ICUI is valued a bit cheaper than 71.51% of the companies in the same industry.
Industry RankSector Rank
P/FCF 56.34
EV/EBITDA 13.99
ICUI Per share dataICUI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60 80

4.3 Compensation for Growth

  • ICUI's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • ICUI's earnings are expected to grow with 14.98% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.76
PEG (5Y)N/A
EPS Next 2Y14.84%
EPS Next 3Y14.98%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • ICUI does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

ICU MEDICAL INC

NASDAQ:ICUI (2/12/2026, 8:00:02 PM)

After market: 142.02 0 (0%)

142.02

-5.71 (-3.87%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-06
Earnings (Next)02-19
Inst Owners118.03%
Inst Owner Change-1.15%
Ins Owners0.96%
Ins Owner Change-1.94%
Market Cap3.51B
Revenue(TTM)2.32B
Net Income(TTM)-7.36M
Analysts83.33
Price Target185.03 (30.28%)
Short Float %4.79%
Short Ratio4.93
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)38.05%
Min EPS beat(2)37.25%
Max EPS beat(2)38.85%
EPS beat(4)4
Avg EPS beat(4)36.86%
Min EPS beat(4)31.74%
Max EPS beat(4)39.58%
EPS beat(8)8
Avg EPS beat(8)33.65%
EPS beat(12)12
Avg EPS beat(12)26.3%
EPS beat(16)15
Avg EPS beat(16)20.15%
Revenue beat(2)1
Avg Revenue beat(2)0.33%
Min Revenue beat(2)-1.77%
Max Revenue beat(2)2.43%
Revenue beat(4)3
Avg Revenue beat(4)1.47%
Min Revenue beat(4)-1.77%
Max Revenue beat(4)3.09%
Revenue beat(8)6
Avg Revenue beat(8)0.95%
Revenue beat(12)6
Avg Revenue beat(12)-0.92%
Revenue beat(16)8
Avg Revenue beat(16)-0.53%
PT rev (1m)0%
PT rev (3m)4.13%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-0.69%
EPS NY rev (1m)-0.44%
EPS NY rev (3m)7.65%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.65%
Revenue NY rev (1m)-0.31%
Revenue NY rev (3m)0.67%
Valuation
Industry RankSector Rank
PE 17.84
Fwd PE 17.31
P/S 1.51
P/FCF 56.34
P/OCF 21.99
P/B 1.65
P/tB N/A
EV/EBITDA 13.99
EPS(TTM)7.96
EY5.6%
EPS(NY)8.2
Fwd EY5.78%
FCF(TTM)2.52
FCFY1.77%
OCF(TTM)6.46
OCFY4.55%
SpS93.98
BVpS86.16
TBVpS-1.47
PEG (NY)0.76
PEG (5Y)N/A
Graham Number124.22
Profitability
Industry RankSector Rank
ROA -0.18%
ROE -0.35%
ROCE 3.62%
ROIC 2.86%
ROICexc 3.12%
ROICexgc 9.01%
OM 5.63%
PM (TTM) N/A
GM 36.47%
FCFM 2.68%
ROA(3y)-1.71%
ROA(5y)1.06%
ROE(3y)-3.65%
ROE(5y)0.24%
ROIC(3y)1.36%
ROIC(5y)3.41%
ROICexc(3y)1.47%
ROICexc(5y)4.61%
ROICexgc(3y)4.17%
ROICexgc(5y)7.18%
ROCE(3y)1.72%
ROCE(5y)4.32%
ROICexgc growth 3Y-18.09%
ROICexgc growth 5Y-16.18%
ROICexc growth 3Y-37.66%
ROICexc growth 5Y-28.8%
OM growth 3Y-26.21%
OM growth 5Y-22.36%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.48%
GM growth 5Y-1.46%
F-Score7
Asset Turnover0.57
Health
Industry RankSector Rank
Debt/Equity 0.62
Debt/FCF 21.21
Debt/EBITDA 3.95
Cap/Depr 47.91%
Cap/Sales 4.19%
Interest Coverage 250
Cash Conversion 47.79%
Profit Quality N/A
Current Ratio 2.45
Quick Ratio 1.19
Altman-Z 2.23
F-Score7
WACC9.69%
ROIC/WACC0.3
Cap/Depr(3y)41.42%
Cap/Depr(5y)66.41%
Cap/Sales(3y)4.1%
Cap/Sales(5y)5.27%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)40.14%
EPS 3Y-5.58%
EPS 5Y-5.28%
EPS Q2Q%27.67%
EPS Next Y23.37%
EPS Next 2Y14.84%
EPS Next 3Y14.98%
EPS Next 5Y14.56%
Revenue 1Y (TTM)-0.84%
Revenue growth 3Y21.86%
Revenue growth 5Y13.47%
Sales Q2Q%-9.48%
Revenue Next Year-4.9%
Revenue Next 2Y-3.64%
Revenue Next 3Y-1.17%
Revenue Next 5Y2.95%
EBIT growth 1Y142.55%
EBIT growth 3Y-10.08%
EBIT growth 5Y-11.9%
EBIT Next Year43.36%
EBIT Next 3Y18.75%
EBIT Next 5Y17.88%
FCF growth 1Y597.89%
FCF growth 3Y-15.14%
FCF growth 5YN/A
OCF growth 1Y117.81%
OCF growth 3Y-8.63%
OCF growth 5Y14.9%

ICU MEDICAL INC / ICUI FAQ

What is the ChartMill fundamental rating of ICU MEDICAL INC (ICUI) stock?

ChartMill assigns a fundamental rating of 4 / 10 to ICUI.


Can you provide the valuation status for ICU MEDICAL INC?

ChartMill assigns a valuation rating of 6 / 10 to ICU MEDICAL INC (ICUI). This can be considered as Fairly Valued.


What is the profitability of ICUI stock?

ICU MEDICAL INC (ICUI) has a profitability rating of 4 / 10.


Can you provide the financial health for ICUI stock?

The financial health rating of ICU MEDICAL INC (ICUI) is 4 / 10.


What is the expected EPS growth for ICU MEDICAL INC (ICUI) stock?

The Earnings per Share (EPS) of ICU MEDICAL INC (ICUI) is expected to grow by 23.37% in the next year.